Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe...
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
About this item
Full title
Author / Creator
Publisher
England: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
A subunit vaccine, RBD-S, is under development to prevent severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV), which is classified by the US NIH as a category C pathogen. This vaccine is comprised of a recombinant receptor-binding domain (RBD) of the SARS-CoV spike (S) protein and formulated on alum, together with a synth...
Alternative Titles
Full title
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1273274109
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1273274109
Other Identifiers
ISSN
1476-0584
E-ISSN
1744-8395
DOI
10.1586/erv.12.126
